scispace - formally typeset
S

Supriya Gupta

Researcher at Academy of Scientific and Innovative Research

Publications -  118
Citations -  9420

Supriya Gupta is an academic researcher from Academy of Scientific and Innovative Research. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 103 publications receiving 8259 citations. Previous affiliations of Supriya Gupta include Rush University Medical Center & G. B. Pant University of Agriculture and Technology.

Papers
More filters
Journal ArticleDOI

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger E. McLendon, +233 more
- 23 Oct 2008 - 
TL;DR: The interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated gliobeasts, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.
Journal ArticleDOI

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

TL;DR: Data suggest that EGFR inhibition using Food and Drug Administration‐approved inhibitors provides a promising therapeutic approach for reduction of fibrogenesis and prevention of HCC in high‐risk cirrhosis patients who can be identified and monitored by gene expression signatures.
Journal ArticleDOI

Nutraceutical Value of Finger Millet [Eleusine coracana (L.) Gaertn.], and Their Improvement Using Omics Approaches.

TL;DR: The role that recent biotechnological advancements have to offer for enrichment of finger millet's nutritional value are highlighted and how these developments can commission to the field of nutritional biology by opening new avenues for future research are highlighted.
Journal ArticleDOI

Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.

TL;DR: Percutaneous ablation is a common treatment for colorectal liver metastasis (CLM) but the effect of rat sarcoma viral oncogene homologue (RAS) mutation on outcome after ablation of CLMs is unclear.